
To help our customers increase the value of our award-winning software, we offer strategic advice and recommendations on syndicating channel sales data across the enterprise, improving channel operations, and fashioning better agreements. Relying on the best practices gleaned from our work with dozens of pharmaceutical manufacturers, we help customers plan and manage their businesses for todayand for the future.

Our industry-tested business consultants provide key insights into how to optimize your current distribution channel and address challenges such as fee-for-service agreements, revenue predictability, inventory level management, chargeback verification, diversion, and more.
Strategic Assessments provide a formal evaluation of current channel policies, internal and external processes, and execution capabilities, leading to concrete recommendations for best-practice improvements. Clear analysis backed by experience with leading pharmaceutical manufacturers can lead directly to improved internal processes, better-informed negotiations with channel partners and increased profitability. A Strategic Assessment includes interviews, a review of industry best practices, benchmarking, IT systems review, a financial impact analysis and actionable recommendations for creating value.
Channel Data Assessments applies rigorous standards to measure the benefits and limitations of channel data currently available to the customer. As channel data volume and costs expand, pharmaceutical manufacturers require a workable strategy for extracting business value from the data. We provide a comprehensive analysis of existing channel data and assess its strategic value across the enterprise. We then recommend best practices for securing additional, useful information from partners.